ChartRow logo
Share this page
PFE
$29.58+0.48%
as of close, Oct 16, 2026
☾ AH $29.58 +0.48%
PeersMRNALLYMDTUNHJNJTMO

PFE financial statements

The full income statement, balance sheet, and cash-flow statement for Pfizer Inc. (PFE), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 5.67B2024-09 5.67B2024-12 5.67B2025-03 5.69B2025-06 5.69B2025-09 5.69B2025-12 5.69B2026-03 5.70B2026-06 5.70B+0.6% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue62.6B-1.6%63.6B+6.8%59.6B-35.1%91.8B+24.7%73.6B+76.8%
Cost of revenue16.1B-10.0%17.9B-28.5%25.0B-27.3%34.3B+11.4%30.8B+263.3%
Research & development10.4B-3.6%10.8B+1.3%10.7B-6.6%11.4B+10.3%10.4B+19.0%
Selling, general & administrative13.8B-6.4%14.7B-0.3%14.8B+8.0%13.7B+7.7%12.7B+9.5%
Restructuring1.09B-45.0%1.99B+1.0%1.97B+123.1%882M+19.0%741M+38.5%
Amortization of intangibles—5.30B+12.8%4.70B+30.6%3.60B-2.7%3.70B+8.8%
Interest expense2.67B-13.6%3.09B+39.9%2.21B+78.4%1.24B-4.1%1.29B-10.9%
Interest & investment income603M+10.6%545M-66.4%1.62B+547.0%251M+597.2%36.0M-50.7%
Other non-operating income-6.72B-53.2%-4.39B-1876.6%-222M+79.1%-1.06B-121.8%4.88B+502.1%
Gain (loss) on equity securities-67.0M-106.6%1.01B-36.6%1.59B+224.9%-1.27B-194.7%1.34B+148.9%
Pre-tax income7.52B-6.3%8.02B+658.3%1.06B-97.0%34.7B+42.9%24.3B+245.5%
Income tax-266M-850.0%-28.0M+97.5%-1.11B-133.5%3.33B+79.7%1.85B+400.5%
7.77B-3.2%8.03B+279.0%2.12B-93.2%31.4B+42.7%22.0B+140.0%
Income from continuing operations
————22.4B+238.1%
Discontinued operations25.0M+127.3%11.0M+173.3%-15.0M-350.0%6.00M+101.4%-434M-117.2%
Net income to non-controlling interest41.0M+32.3%31.0M-20.5%39.0M+11.4%35.0M-22.2%45.0M+25.0%
Net income to common7.77B-3.2%8.03B+279.0%2.12B-93.2%31.4B+42.7%22.0B+140.0%
$1.36-3.5%$1.41+281.1%$0.37-93.2%$5.47+42.1%$3.85+136.2%
EPS (basic)$1.37-3.5%$1.42+273.7%$0.38-93.2%$5.59+42.6%$3.92+137.6%
Weighted-avg shares (basic)5.68B+0.3%5.66B+0.4%5.64B+0.6%5.61B+0.1%5.60B+0.8%
Weighted-avg shares (diluted)5.71B+0.2%5.70B-0.2%5.71B-0.4%5.73B+0.4%5.71B+1.3%
Dividends per share$1.72+1.8%$1.69+2.4%$1.65+2.5%$1.61+2.5%$1.57+2.6%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
42.9B-14.8%50.4B+16.2%43.3B-15.5%51.3B-14.1%59.7B+70.2%
Cash & equivalents1.14B+9.5%1.04B-63.4%2.85B+585.8%416M-78.6%1.94B+8.8%
Accounts receivable11.9B+3.6%11.5B-0.9%11.6B+5.6%11.0B-4.6%11.5B+45.1%
Inventory10.7B-1.8%10.9B+6.5%10.2B+13.5%8.98B-0.9%9.06B+13.0%
Other current assets2.81B-34.0%4.25B-13.4%4.91B-2.1%5.02B+31.3%3.82B+4.8%
208B-2.5%213B-5.8%227B+14.9%197B+8.7%181B+17.7%
Property, plant & equipment19.3B+5.0%18.4B-2.9%18.9B+16.4%16.3B+9.4%14.9B+8.3%
Operating lease right-of-use2.21B-3.3%2.29B-21.7%2.92B-2.6%3.00B+5.7%2.84B+104.8%
Goodwill71.3B+4.0%68.5B+1.1%67.8B+31.9%51.4B+4.4%49.2B-0.7%
Intangible assets53.7B-3.0%55.4B-14.6%64.9B+49.6%43.4B+72.5%25.1B-11.3%
Long-term investments—2.23B-85.5%15.4B+2.0%15.1B-30.0%21.5B+6.2%
Other non-current assets9.63B-1.9%9.82B-21.3%12.5B-5.3%13.2B+71.4%7.68B+57.4%
37.0B-14.0%43.0B-10.0%47.8B+13.4%42.1B-1.2%42.7B+64.6%
Accounts payable5.24B-7.0%5.63B-16.1%6.71B-1.5%6.81B+22.1%5.58B+30.2%
Deferred revenue784M-48.1%1.51B-44.0%2.70B+7.1%2.52B-17.8%3.07B+175.6%
Short-term & current debt3.00B-20.0%3.75B+66.2%2.25B-12.0%2.56B+56.5%1.64B-18.3%
Current lease liability330M-7.3%356M-32.4%527M-15.0%620M+38.1%449M+40.3%
Other current liabilities19.4B-1.5%19.7B-4.0%20.5B-9.0%22.6B-9.5%24.9B+115.7%
121B-2.8%125B-9.0%137B+35.5%101B-2.6%104B+14.6%
Long-term debt61.6B+7.4%57.4B-6.7%61.5B+87.1%32.9B-9.1%36.2B-2.5%
Non-current lease liability2.29B+0.2%2.29B-12.9%2.63B+1.1%2.60B+3.5%2.51B+126.5%
Operating lease liability (total)2.62B-0.8%2.64B-16.2%3.15B-2.0%3.22B+8.7%2.96B+106.3%
Deferred tax liabilities2.40B+13.1%2.12B+231.6%640M-37.4%1.02B+193.1%349M-91.4%
Other non-current liabilities14.7B+4.1%14.2B-14.4%16.5B+25.5%13.2B+35.3%9.74B+46.1%
86.5B-2.0%88.2B-0.9%89.0B-6.9%95.7B+23.9%77.2B+22.1%
Preferred stock——0.000.000.00
Common stock481M+0.2%480M+0.4%478M+0.4%476M+0.6%473M+0.6%
Additional paid-in capital94.5B+0.9%93.6B+1.0%92.6B+0.9%91.8B+1.3%90.6B+2.2%
Retained earnings115B-1.8%117B-1.4%118B-5.8%126B+21.5%103B+14.4%
Treasury stock115B+0.2%115B+0.2%114B+0.5%114B+2.3%111B+0.3%
Accumulated other comprehensive income-8.07B-2.9%-7.84B+1.5%-7.96B+4.1%-8.30B-40.8%-5.90B-11.1%
Non-controlling interest299M+1.7%294M+7.3%274M+7.0%256M-2.3%262M+11.5%
Total equity incl. non-controlling86.8B-1.9%88.5B-0.9%89.3B-6.9%95.9B+23.8%77.5B+22.0%
Total liabilities & equity208B-2.5%213B-5.8%227B+14.9%197B+8.7%181B+17.7%
Common shares issued9.62B+0.3%9.59B+0.3%9.56B+0.5%9.52B+0.5%9.47B+0.7%
Shares outstanding (cover)5.69B+0.3%5.67B+0.4%5.65B+0.5%5.62B-0.1%5.62B+0.8%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
11.7B-8.2%12.7B+46.5%8.70B-70.3%29.3B-10.2%32.6B+126.2%
Depreciation & amortization6.59B-6.0%7.01B+11.5%6.29B+24.2%5.06B-2.4%5.19B+10.9%
Intangible amortization—5.30B+12.8%4.70B+30.6%3.60B-2.7%3.70B+8.8%
Share-based compensation799M-8.9%877M+67.0%525M-39.8%872M-26.2%1.18B+56.6%
Deferred income taxes-2.13B-1.5%-2.10B+38.9%-3.44B+8.6%-3.76B+12.3%-4.29B-172.6%
Change in receivables263M+141.3%109M+131.4%-347M-33.0%-261M-106.8%3.81B+198.9%
Change in inventory-561M-165.7%854M-26.9%1.17B+97.8%591M-47.5%1.13B+44.6%
-1.35B-150.9%2.65B+108.2%-32.3B-104.5%-15.8B+30.0%-22.5B-427.9%
Capital expenditure2.63B-9.6%2.91B-25.5%3.91B+20.7%3.24B+19.4%2.71B+21.8%
Free cash flow9.07B-7.7%9.84B+105.2%4.79B-81.6%26.0B-12.8%29.9B+145.3%
Acquisitions6.93B0.00-100.0%43.4B+88.9%23.0B0.00
Other investing activities-165M-8150.0%-2.00M-101.1%179M-6.8%192M-37.0%305M+15.1%
-10.3B+39.9%-17.1B-165.8%26.1B+275.7%-14.8B-51.1%-9.82B-1.7%
Long-term debt issued9.68B0.00-100.0%30.8B0.00-100.0%997M-80.9%
Long-term debt repaid6.76B+200.3%2.25B-12.4%2.57B-22.1%3.30B+64.6%2.00B-49.9%
Common stock issued0.000.000.000.000.00
Common stock repurchased0.000.000.00-100.0%2.00B0.00
Dividends paid9.77B+2.7%9.51B+2.9%9.25B+2.9%8.98B+2.9%8.73B+3.4%
Other financing activities-458M+2.3%-469M+25.7%-631M-88.4%-335M-2193.8%16.0M+103.6%
FX effect on cash41.0M+162.1%-66.0M-65.0%-40.0M+75.8%-165M-179.7%-59.0M-637.5%
Net change in cash91.0M+105.0%-1.81B-173.9%2.45B+261.6%-1.51B-1052.8%159M-66.5%
Interest paid2.74B-15.1%3.23B+45.7%2.21B+53.6%1.44B-1.7%1.47B-10.6%
Income taxes paid4.69B+30.0%3.60B+14.6%3.15B-60.0%7.87B+5.9%7.43B+135.6%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap142B-5.8%150B-7.5%163B-43.5%288B-13.4%332B+61.7%
P/E18.2×-2.7%18.7×+20.7%15.5×+60.5%9.7×-36.1%15.1×-32.6%
P/S2.3×-4.3%2.4×+1.6%2.3×-25.4%3.1×-30.8%4.5×-8.5%
P/B1.6×-3.9%1.7×+1.6%1.7×-46.0%3.1×-27.8%4.3×+32.5%
P/FCF15.6×+2.1%15.3×-23.1%19.9×+61.5%12.3×+10.7%11.1×-34.1%
Earnings yield5.5%+2.8%5.3%-17.2%6.4%-37.7%10.4%+56.4%6.6%+48.4%
FCF yield6.4%-2.0%6.5%+30.0%5.0%-38.1%8.1%-9.7%9.0%+51.7%
Dividend yield6.9%+8.4%6.4%+11.1%5.7%+82.4%3.1%+18.2%2.7%-36.0%
Source filing10-K10-K10-K10-K10-K

About this data

Source: PFE’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all PFE filings on SEC EDGAR → Not investment advice.